Public preview. Funding rounds, founders, and growth signals require a free account.
Unlock full profile
Asimov
Asimov builds tools to program living cells by integrating synthetic biology, computer-aided design, and machine learning for biologics and gene therapies.
Series BBiotechBoston, MA51-200 employees
Last round
Series B
Jan 2023
Stage
Series B
Status
Active
Founders & team
Growth signals
Track Asimov on FlareSight
Get notified the moment Asimov files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.